{
    "2018-07-10": [
        [
            {
                "time": "2018-07-15",
                "original_text": "Trump Tweets Threat to Pfizer but Investors Shrug it Off",
                "features": {
                    "keywords": [
                        "Trump",
                        "Tweets",
                        "Threat",
                        "Pfizer"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-16",
                "original_text": "Biogen Is the Right Alzheimer’s Stock … At the Wrong Time",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Alzheimer’s",
                        "Stock",
                        "Wrong Time"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-17",
                "original_text": "A Look at Incyte’s Product Portfolio in July",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Product",
                        "Portfolio",
                        "July"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-18",
                "original_text": "Incyte’s Quarterly Revenue Stream",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Quarterly",
                        "Revenue",
                        "Stream"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}